Mingli Gong

1.9k total citations · 1 hit paper
16 papers, 1.0k citations indexed

About

Mingli Gong is a scholar working on Infectious Diseases, Molecular Biology and Immunology. According to data from OpenAlex, Mingli Gong has authored 16 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 7 papers in Molecular Biology and 3 papers in Immunology. Recurrent topics in Mingli Gong's work include SARS-CoV-2 and COVID-19 Research (5 papers), interferon and immune responses (3 papers) and Viral Infections and Outbreaks Research (3 papers). Mingli Gong is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (5 papers), interferon and immune responses (3 papers) and Viral Infections and Outbreaks Research (3 papers). Mingli Gong collaborates with scholars based in China, United States and Australia. Mingli Gong's co-authors include Jing Zhang, Wenyan Wang, Yiping Li, Charles R. Mackay, Xiaohuan Guo, Yao He, Jiaoyan Huang, Yun Chen, Yang‐Xin Fu and Qiang Ding and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Cell Metabolism.

In The Last Decade

Mingli Gong

15 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gut microbial metabolites facilitate anticancer therapy efficacy by modulating cytotoxic CD8+ T cell immunity

2021 480 citations Yao He, Liuhui Fu et al. Cell Metabolism profile →

Peers

Countries citing papers authored by Mingli Gong

Since Specialization

Citations

This map shows the geographic impact of Mingli Gong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingli Gong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingli Gong more than expected).

Fields of papers citing papers by Mingli Gong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingli Gong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingli Gong. The network helps show where Mingli Gong may publish in the future.

Co-authorship network of co-authors of Mingli Gong

This figure shows the co-authorship network connecting the top 25 collaborators of Mingli Gong. A scholar is included among the top collaborators of Mingli Gong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingli Gong. Mingli Gong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Integrating InSAR, ICA, and geophysical models to decipher the kinematics of Huangtupo landslide 2025 ·Geomatics Natural Hazards and Risk ·Ya Kang, Wei Qu, Zhong Lu, (unknown), Zongxing Zou, Mingli Gong, (unknown)	0
2	Genome-wide CRISPR/Cas9 screen identifies SLC39A9 and PIK3C3 as crucial entry factors for Ebola virus infection 2024 ·PLoS Pathogens ·Mingli Gong, (unknown), Yang Chen, Zhenhua Wang, Hongwu Qian, Xue Hu, Peng Zhou, Chao Shan, Qiang Ding	4
3	Zika virus NS5 protein inhibits type I interferon signaling via CRL3 E3 ubiquitin ligase-mediated degradation of STAT2 2024 ·Proceedings of the National Academy of Sciences ·Wenlin Ren, (unknown), Yu Zhang, Xiaohui Ju, Xi Zhuo Jiang, (unknown), Mingli Gong, Zhuoyang Li, Wenchun Fan, Jun Yao, Qiang Ding	18
4	Establishment of replication-competent vesicular stomatitis virus recapitulating SADS-CoV entry 2024 ·Journal of Virology ·(unknown), Yutong Han, Mingli Gong, Bo Sun, Rong Zhang, Qiang Ding	3
5	Modeling antiviral response in the liver using human pluripotent stem cell-derived macrophages 2024 ·PubMed ·Yaxuan Zhang, (unknown), Fuyu Duan, Huimin Qiao, Mingli Gong, Hui Qiu, Xia Chen, (unknown), (unknown), Qiang Ding, Jie Na	1
6	Risk of venous thromboembolism with janus kinase inhibitors in inflammatory immune diseases: a systematic review and meta-analysis 2023 ·Frontiers in Pharmacology ·(unknown), Wenhui Li, Mingli Gong, Yanlun Gu, Hanxu Zhang, (unknown), (unknown), Xiaocong Pang, Qian Xiang, (unknown), Yimin Cui	23
7	Identification of potential ferroptosis-associated biomarkers in rheumatoid arthritis 2023 ·Frontiers in Immunology ·(unknown), (unknown), Mingli Gong, Yanlun Gu, (unknown), Xiaocong Pang, Chenglong Zhang, Yimin Cui	20
8	Identification of immune‐associated signatures and potential therapeutic targets for pulmonary arterial hypertension 2023 ·Journal of Cellular and Molecular Medicine ·(unknown), Jiansong Fang, Mingli Gong, (unknown), Ran Xie, (unknown), Yanlun Gu, Lingyue Ma, Xiaocong Pang, Yimin Cui	6
9	Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune Evasion 2022 ·mBio ·Wenlin Ren, Xiaohui Ju, Mingli Gong, Jun Lan, Yanying Yu, Quanxin Long, Devin Kenney, Aoife K. O’Connell, Yu Zhang, Jin Zhong, Guocai Zhong, Florian Douam, Xinquan Wang, Ailong Huang, Rong Zhang, Qiang Ding	23
10	A novel cell culture system modeling the SARS-CoV-2 life cycle 2021 ·PLoS Pathogens ·Xiaohui Ju, Yunkai Zhu, Yuyan Wang, Jingrui Li, Jiaxing Zhang, Mingli Gong, Wenlin Ren, Sai Li, Jin Zhong, Linqi Zhang, Qiangfeng Cliff Zhang, Rong Zhang, Qiang Ding	117
11	Mutation Y453F in the spike protein of SARS-CoV-2 enhances interaction with the mink ACE2 receptor for host adaption 2021 ·PLoS Pathogens ·Wenlin Ren, Jun Lan, Xiaohui Ju, Mingli Gong, Quanxin Long, (unknown), Yanying Yu, Jianping Wu, Jin Zhong, Rong Zhang, Shilong Fan, Guocai Zhong, Ailong Huang, Xinquan Wang, Qiang Ding	48
12	In vivo structural characterization of the SARS-CoV-2 RNA genome identifies host proteins vulnerable to repurposed drugs 2021 ·Cell ·Lei Sun, Pan Li, Xiaohui Ju, Jian Rao, Wenze Huang, Lili Ren, Shaojun Zhang, Tuanlin Xiong, Kui Xu, Xiaolin Zhou, Mingli Gong, Eric A. Miska, Qiang Ding, Jianwei Wang, Qiangfeng Cliff Zhang	153
13	Novel quinolone derivatives targeting human dihydroorotate dehydrogenase suppress Ebola virus infection in vitro 2021 ·Antiviral Research ·Mingli Gong, Yiqing Yang, Yi Huang, (unknown), Yue Wu, Hongying Gao, Qianqian Li, Jianhui Nie, Weijin Huang, Youchun Wang, Rong Zhang, Jin Zhong, Fēi Dèng, Yu Rao, Qiang Ding	13
14	Comparison of viral RNA–host protein interactomes across pathogenic RNA viruses informs rapid antiviral drug discovery for SARS-CoV-2 2021 ·Cell Research ·Shaojun Zhang, Wenze Huang, Lili Ren, Xiaohui Ju, Mingli Gong, Jian Rao, Lei Sun, Pan Li, Qiang Ding, Jianwei Wang, Qiangfeng Cliff Zhang	74
15	Gut microbial metabolites facilitate anticancer therapy efficacy by modulating cytotoxic CD8+ T cell immunity breakdown → 2021 ·Cell Metabolism ·Yao He, Liuhui Fu, Yiping Li, Wenyan Wang, Mingli Gong, Jing Zhang, Xin Dong, Jiaoyan Huang, Quanbo Wang, Charles R. Mackay, Yang‐Xin Fu, Yun Chen, Xiaohuan Guo	480
16	Identification of functional cis-acting RNA elements in the hepatitis E virus genome required for viral replication 2020 ·PLoS Pathogens ·Xiaohui Ju, (unknown), Mingli Gong, Rui Yang, (unknown), Yafei Li, Yuchen Nan, Yonglin Yang, Qiangfeng Cliff Zhang, Qiang Ding	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact